A Two-Part Phase Ib/II Study to Investigate the Pharmacokinetics, Efficacy, and Safety of Atezolizumab Subcutaneous in Patients With Stage IV Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab; Carboplatin; Hyaluronidase; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Roche
- 17 Dec 2018 Status changed from not yet recruiting to recruiting.
- 26 Nov 2018 Planned initiation date changed from 14 Nov 2018 to 28 Dec 2018.
- 15 Nov 2018 New trial record